Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FR1JJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,332
Award facts
- Contract value 100% obligated
- $8,331.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $8,331.72 to DMS Pharmaceutical Group Inc. for the supply of Nexplanon 68 mg implants, a subdermal contraceptive device. The delivery order, issued on August 22, 2025, with completion expected by September 15, 2025, represents a discrete task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award carries no set-aside designation, and performance will be executed from the contractor's location in Park Ridge, Illinois.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has been registered in SAM.gov since 2001 and serves as a critical supplier within the federal pharmaceutical supply chain. The company holds a significant single-award IDC with DLA valued at $499,999,999 and valid through November 2026 under the SPE2DB program, which authorizes the issuance of firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products supporting military health facilities worldwide. This delivery order for Nexplanon implants exemplifies the types of specialized pharmaceutical products DMS Pharmaceutical Group routinely delivers to Department of Defense healthcare sites as part of its core business of distributing branded and generic prescription drugs, biologics, contraceptive devices, and medical consumables to federal agencies.
Quick answers
Who was awarded contract SPE2DB25FR1JJ?
SPE2DB25FR1JJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FR1JJ worth?
The government has obligated $8,332 on SPE2DB25FR1JJ.
Is contract SPE2DB25FR1JJ an order under another contract?
Yes. SPE2DB25FR1JJ is a delivery order under SPE2DB22D9251, an indefinite delivery contract.
Was contract SPE2DB25FR1JJ competed?
The extent of competition for SPE2DB25FR1JJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award